Shots: The EC has granted conditional marketing authorization to Ervebo for active immunization of individuals aged ≥ 18yrs. to protect against Ebola virus disease (EVD) caused by Zaire Ebola virus […]readmore
![Merck’s Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Receives EC’s Conditional Approval to Prevent Ebola Virus Disease](https://pharmashots.in/wp-content/uploads/2019/11/Merck-18-850x560.jpg)
Tags : rVSVΔG-ZEBOV-GP